Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2007
03/22/2007US20070066683 Selective peroxisome proliferator activated receptor modulators
03/22/2007US20070066682 Arylalkylamine vanadium (V) salts for the treatment and/or prevention of Diabetes mellitus
03/22/2007US20070066681 Pharmaceutical composition for treating fatty liver or hepatic disease
03/22/2007US20070066680 Benzofurans and benzothiophenes
03/22/2007US20070066679 Crystalline sodium atorvastatin
03/22/2007US20070066678 Crystalline sodium atorvastatin
03/22/2007US20070066677 serine proteases such as dipeptidyl peptidases inhibitor; antidiabetic agent; metabolic disorders, hyperglycosemia, hyperglycosemia, gastrointestinal, viral, autoimmune, dermatological, psychosomatic, depressive, and neuropsychiatric disorders, obesity, psoriasis, intestinal distress, arthritis
03/22/2007US20070066676 2-(2,3,3a,8b-Tetrahydro-1H-cyclopenta[b]indol-4-yl-substituted acetamides, acetonitriles and ethylamines as intermediates
03/22/2007US20070066675 5-Aryl-indan-1-one and analogs useful as progesterone receptor modulators
03/22/2007US20070066672 Benzimidazole derivatives and use thereof as peptide deformylase inhibitors
03/22/2007US20070066671 Substituted benzimidazoles, production and use thereof as agents for combating parasitic protozoas
03/22/2007US20070066670 Substituted benzimidazoles and their use for inducing apoptosis
03/22/2007US20070066668 Isoxazolo derivatives
03/22/2007US20070066667 Novel thiophene sulfoximines, compositions thereof, and methods treating complement-mediated diseases and conditions
03/22/2007US20070066666 Thiazole compounds
03/22/2007US20070066665 Compounds and methods for the diagnosis and treatment of amyloid associated diseases
03/22/2007US20070066664 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses, materials for their synthesis
03/22/2007US20070066663 disorders of the central and/or peripheral nervous system; minimal interaction with metabolic enzymes, improved selectivity, potentiation, acid resistance, bioavailibility; (3S) N-(2-Methylpropyl)-N-{[2-(trifluoromethyl)-phenyl]methyl}piperidin-3-amine; depression, urinary incontinence; pain
03/22/2007US20070066662 Catalytically reducing 5-{4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzylidene}-2,4-thiazolidinedione or its salt or hydrate at above 70 degrees C. using a hydrogen pressure above 20 psi, to form 5-{4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl}-2,4-thiazolidinedione
03/22/2007US20070066661 Methods and Compositions for the Treatment of Alopecia and Other Disorders of the Pilosebaceous Apparatus
03/22/2007US20070066660 e.g. (5-chloro-6-trifluoromethyl-1H-benzimidazol-2-yl)[4-(pyridin-4-yloxy) phenyl]amine; tyrosine kinases receptor (such as TIE-2) inhibitor; anticarcinogenic, antiinflammatory agent; autoimmune diseases; rheumatoid arthritis, psoriasis, contact dermatitis, leukaemia, lung adenocarcinoma
03/22/2007US20070066659 Use of tenatoprazole for the treatment of gastroesophageal reflux disease
03/22/2007US20070066658 N-{4-[4-(2-Benzylamino-ethyl)-phenoxy]-phenyl}-acetamide; eating disorders; antidiabetic, -arthritic, -epileptic, anxiolytic -lipedemic agents; anxiolytic, hypoglycemic and hypotensive agents; sexual disorders, antidepressants, hypertriglycemia, hyperlipoproteinemia, drug abuse; behavior disorders
03/22/2007US20070066657 Biphenyl-pyrazolecarboxamide compounds
03/22/2007US20070066656 Novel stable polymorphic forms of an anticonvulsant
03/22/2007US20070066655 Diarylmethylidene piperidine derivatives and their use as delta opiod receptor agonists
03/22/2007US20070066654 Using4,4-dimethyl-6-methyleme-2-cyclohexene-1-one
03/22/2007US20070066653 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
03/22/2007US20070066652 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
03/22/2007US20070066651 Pyrazoline derivatives useful for the treatment of cancer
03/22/2007US20070066650 (R)-6-(2-(2,2,2-Trifluoroethyl)-1-pyrrolidinyl)-4-trifluoromethyl-2(1H)-quinolinone; partial agonist, agonist or antagonist of androgen receptor; cachexia and wasting diseases; male-pattern baldness; benign prostatic hyperplasia; hirsutism; acne
03/22/2007US20070066649 Method of treating or inhibiting the development of brain inflammation and sepsis
03/22/2007US20070066648 Method of treating or inhibiting the development of brain inflammation and sepsis
03/22/2007US20070066647 3-(4-(4-Bromo-2,3-dihydro-1H-inden-1-yloxy)phenyl)hex-4-ynoic and the methyl ester; G-protein coupled receptor 40 (GPR40) modulators; antidiabetic agents; non-insulin dependent diabetes; obesity; hypotensive agents; syndrome X; urogenital disorders; sexual disorders; anticarcinogenic agents
03/22/2007US20070066646 Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof
03/22/2007US20070066645 Novel compounds
03/22/2007US20070066644 1-[[1-[(2-Amino-6-methyl-4-pyridinyl)methyl]-4-fluoro-4-piperidinyl]carbonyl]-4-[2-(2-pyridinyl)-3H-imidazo[4,5-b]pyridin-3-yl]piperidine
03/22/2007US20070066643 Methods of treating middle-of-the-night insomnia
03/22/2007US20070066642 Novel imidazopyridine compound ii with therapeutic effect
03/22/2007US20070066641 Compounds and methods for development of RET modulators
03/22/2007US20070066640 Heteroaryl-substituted pyrrolo'2,3-b1 pyridine derivatives as crf receptor antagonists
03/22/2007US20070066639 Oxime substituted imidazoquinolines
03/22/2007US20070066638 Ryanodine receptor blockers for treating pain
03/22/2007US20070066637 5-Aryl-indan-1-one oximes and analogs useful as progesterone receptor modulators
03/22/2007US20070066636 Polymorphs of tartrate salt of 2-[2-(3-(r)-amino-piperidin-1-yl)-5-fluoro-6-oxo-6h-pyrimidin-1-ylmethyl]-benzonitrile and methods of use therefor
03/22/2007US20070066635 Polymorphs of benzoate salt of 2-[[6-[(3r)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2h)-pyrimidinyl]methyl]-benzonitrile and methods of use therefor
03/22/2007US20070066634 Tetrahydropyridin-4-yl indoles with a combination of affinity for dopamine-d2 receptors and serotonin reuptake sites
03/22/2007US20070066633 Angiogenesis inhibitor; anticancer agents; antiarthritic agents; psoriasis
03/22/2007US20070066632 Fused bicyclic inhibitors of TGFbeta
03/22/2007US20070066631 A2B adenosine receptor antagonists; asthma, improving insulin sensitivity
03/22/2007US20070066630 nicotinic acid receptor agonists comprising pyrano[2,3-d]pyrimidine derivatives, useful for treating metabolic syndrome, dyslipidemia, diabetes, nervous system disorders, cancer, inflammation, cardiovascular, respiratory, gastroenterological, hematological and fatty liver disease
03/22/2007US20070066628 5-Aryl-indan-1-ol and analogs useful as progesterone receptor modulators
03/22/2007US20070066626 Compounds, compositions and methods
03/22/2007US20070066625 Method of treating parkinson's disease with diarylmethylpiperazine compounds exhibiting delta receptor agonist activity
03/22/2007US20070066624 Chemokine receptor binding compounds
03/22/2007US20070066623 Entry inhibitors of the hiv virus
03/22/2007US20070066622 2-(3-Phenyl-2-piperazinyl-3,4-dihydroquinazolin-4-yl)acetic acids as antiviral agents, especially against cytomegaloviruses
03/22/2007US20070066621 Novel 4-cyano, 4-amino, and 4-aminomethyl derivatives of pyrazolo[1,5-a]pyridines, pyrazolo[1,5-c]pyrimidines and 2h-indazole compounds and 5-cyano, 5-amino, and 5-aminomethyl derivatives of imidazo[1,2-a]pyridines, and imidazo[1,5-a]pyrazines as cyclin dependent kinase inhibitors
03/22/2007US20070066620 central nervous system disorders including movement disorders, Extra Pyramidal Syndrome; compounds can be use with other agents useful in treating Parkinson's disease
03/22/2007US20070066619 Compounds having simultaneous ability to block L-type calcium channels and to inhibit phosphodiesterase type 3 activity
03/22/2007US20070066618 Use of EP4 Receptor Ligands in the Treatment of IL-6 Involved Diseases
03/22/2007US20070066617 Insecticidal and acaricidal activity for many agricultural insect pests, spider mites; endo- or ecto-parasiticide for mammals or birds; veterinary medicine; environmentally friendly
03/22/2007US20070066616 Inhibitors for extracellular signal-regulated kinase docking domains and uses therefor
03/22/2007US20070066615 Heterocyclic compounds
03/22/2007US20070066614 Ihibitors of 11-beta-hydroxy steroid dehydrogenase type 1
03/22/2007US20070066613 (S)-2-[2-(3,5-Difluoro-phenyl)-acetylamino]-pentanoic acid {1-[2-(3-ethoxy-propylamino) -ethyl]-1H-imidazol-4-yl}-amide, having beta-amyloid peptide production inhibitory activity, used for the treatment of neurodegenerative disorders such as Alzheimer's disease
03/22/2007US20070066612 N-[4-Amino-6-methyl-2-(4-trifluoromethylbenzylamino)-pyrimidin-5-yl]-2-cyclopentylacetamide; potassium ion channels modulators; epilepsy; seizure , anxiety , neuropathic pain and migraine pain disorders
03/22/2007US20070066611 Reacting 4-(4-nitrophenyl)-3-morpholinone with hydrogen in the presence of a hydrogenation catalyst, characterized in that reaction is effected in an aliphatic alcohol; precursor in synthesis of 5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}methyl)-2-thiophenecarboxamide
03/22/2007US20070066610 (S)-4-Bromo-3-[(2-2,3-dihydro-benzofuran-5-yl-acetyl)-hydrazono]-2-oxo-2,3-dihydro-1H-indole-6-carboxylic acid [3-(2-hydroxymethyl-pyrrolidin-1-yl)-propyl]-amide; for treating conditions such as cancers and other cell proliferative disorders
03/22/2007US20070066609 Long acting beta-2-agonists and their use as medicaments
03/22/2007US20070066608 Novel indole derivatives with an improved antipsychotic activity
03/22/2007US20070066607 5-[R-2-(1S,2S-2-Cyclohexylcyclopentylamino)-1-hydroxyethyl]-8-hydroxy-1H-quinolin-2-one, useful for treating conditions that are prevented or alleviated by activation of the adrenergic recptors
03/22/2007US20070066606 Benzylbenzimidazolyl derivatives
03/22/2007US20070066604 Diaminoalcohols as therapeutic compounds
03/22/2007US20070066603 Method for alleviating climacteric symtoms
03/22/2007US20070066602 Process for Making Olanzapine Form I
03/22/2007US20070066601 Combination of a serotonin reuptake inhibitor and a histamine 3 receptor antagonist, inverse agonist or partial agonist
03/22/2007US20070066600 Compounds
03/22/2007US20070066599 New compounds
03/22/2007US20070066598 Compounds
03/22/2007US20070066597 Thiazolidinone, oxazolidinone, and imidazolone derivatives for treating lower urinary tract and related disorders
03/22/2007US20070066595 Selective estrogen receptor modulators
03/22/2007US20070066594 Crystalline forms fenoldopam mesylate
03/22/2007US20070066593 Use of carbamazepine derivatives for the treatment of agitation in dementia patients
03/22/2007US20070066592 5-{6-[(3R)-1-azabicyclo[2.2.2]oct-3-yloxy]pyridazin-3-yl}-1H-indole; attention deficit disorder, attention deficit hyperactivity disorder, Alzheimer's disease, senile dementia, AIDS dementia, Pick's Disease, dementia associated with Down's syndrome; alpha 7 nAChR ligands modulators
03/22/2007US20070066591 Compounds for treatment of cell proliferation disorder and prevention of kinesins
03/22/2007US20070066590 Phenyl-and pyridylpiperidine-derivatives as modulators of glucose metabolism
03/22/2007US20070066589 Method of preparing 10th-dibenzo[b,f][11,4]thiazepin-11-one
03/22/2007US20070066588 Benzothiazole cyclobutyl amine derivatives
03/22/2007US20070066587 Substituted azetidine compounds, their preparation and use as medicaments
03/22/2007US20070066586 Aniline derivatives
03/22/2007US20070066585 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents
03/22/2007US20070066584 Cycloalkylcarbonyl-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-ones: 1'-{[1-(4-Chlorophenyl)cyclo-pentyl]carbonyl}-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-one; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; antidiabetic agents
03/22/2007US20070066583 Monocyclic and bicyclic compounds and methods of use
03/22/2007US20070066582 Diaminoalcohols as therapeutic compounds
03/22/2007US20070066581 Deoxynojirimycin analogues and their uses as glucosylceramidase inhibitors
03/22/2007US20070066580 Novel aldosterone antagonists and uses thereof
03/22/2007US20070066579 5-androsten-3beta-ol steroid intermediates and processs for their preparation
03/22/2007US20070066578 5-Aminosalicylic acid solid preparation improved in discoloration and method of storing the same
03/22/2007US20070066577 Benzoxazole derivative or analogue thereof for inhibiting 5-lipoxygenase and pharmaceutical composition containing same
1 ... 3828 3829 3830 3831 3832 3833 3834 3835 3836 3837 3838 3839 3840 3841 3842 3843 3844 3845 3846 3847 3848 ... 7860